Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 91, Issue 9, Pages 960-967Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2020-323487
Keywords
-
Categories
Funding
- Italian Ministry of Health (Ricerca Corrente)
- Swedish Research Council [2018-02532, 2017-00915]
- European Research Council [681712]
- Swedish State Support for Clinical Research [ALFGBG-720931]
- Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862, RDAPB-201809-2016615]
- UK Dementia Research Institute at UCL
- Swedish Alzheimer Foundation [AF-742881]
- Hjarnfonden, Sweden [FO2017-0243]
- European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]
- Swedish government [ALFGBG-715986]
- County Councils, the ALF--agreement [ALFGBG-715986]
Ask authors/readers for more resources
Objective: To assess the diagnostic and prognostic value of serum neurofilament light (NfL) and serum phospho-Tau(181)(p-Tau(181)) in a large cohort of patients with frontotemporal lobar degeneration (FTLD). Methods: In this retrospective study, performed on 417 participants, we analysed serum NfL and p-Tau(181)concentrations with an ultrasensitive single molecule array (Simoa) approach. We assessed the diagnostic values of serum biomarkers in the differential diagnosis between FTLD, Alzheimer's disease (AD) and healthy ageing; their role as markers of disease severity assessing the correlation with clinical variables, cross-sectional brain imaging and neurophysiological data; their role as prognostic markers, considering their ability to predict survival probability in FTLD. Results: We observed significantly higher levels of serum NfL in patients with FTLD syndromes, compared with healthy controls, and lower levels of p-Tau(181)compared with patients with AD. Serum NfL concentrations showed a high accuracy in discriminating between FTLD and healthy controls (area under the curve (AUC): 0.86, p<0.001), while serum p-Tau(181)showed high accuracy in differentiating FTLD from patients with AD (AUC: 0.93, p<0.001). In FTLD, serum NfL levels correlated with measures of cognitive function, disease severity and behavioural disturbances and were associated with frontotemporal atrophy and indirect measures of GABAergic deficit. Moreover, serum NfL concentrations were identified as the best predictors of survival probability. Conclusions: The assessment of serum NfL and p-Tau(181)may provide a comprehensive view of FTLD, aiding in the differential diagnosis, in staging disease severity and in defining survival probability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available